Clinical Trial Update: Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating an accelerated cytarabine consolidation schedule for older patients with acute myeloid leukemia in complete remission has been termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)

Snippet

Sponsor: University of Florida | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2025-01-16